» Articles » PMID: 15363818

Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 Levels in Patients with Hypertension Relationship to Tissue Doppler Indices of Diastolic Relaxation

Overview
Journal Am J Hypertens
Date 2004 Sep 15
PMID 15363818
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hypertension, hypertensive heart disease, and left ventricular (LV) hypertrophy are integral to symptomatic diastolic heart failure. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is linked to extracellular matrix fibrosis and is elevated in hypertension. We hypothesized a link between circulating TIMP-1, matrix metalloproteinase-9 (MMP-9), and resting echocardiographic LV filling parameters using tissue Doppler parameters of diastolic (dys)function.

Methods: Circulating MMP-9 and TIMP-1 levels were measured in citrated plasma by ELISA in 74 patients with hypertension (58 men, mean age 58 +/- 11 years) and 34 controls (23 men, mean age 53 +/- 13 years). All had confirmed normal short axis systolic contractility, with no significant wall motion abnormalities; the LV mass and standard resting tissue Doppler echocardiographic indices of diastolic function were also recorded.

Results: Both MMP-9 and TIMP-1 levels were higher in the hypertensive group (P =.0039 and P =.0054, respectively). When compared to controls, hypertensive patients had a greater LV mass (P =.0054), and differences in many of the parameters reflecting diastolic dysfunction (controls versus hypertensives: E: 0.71 +/- 0.15 v 0.81 +/- 0.15 m/sec, P =.004; A: 0.66 +/- 0.12 v 0.81 +/- 0.16 m/sec, P <.0001; e': 0.12 (0.09-0.14) v 0.09 (0.07-0.10) m/sec, P =.0017; e'/a': 1.20 (1.00-1.80) v 0.88 (0.71-1.05), P <.0001; E/e': 6.54 (4.75-7.14) v 8.89 (7.55-10.75), P <.0001, respectively). Within the hypertensive cohort, only TIMP-1 levels correlated with LV mass (r = 0.271, P =.024), LV mass index (r = 0.323, P =.007), and tissue Doppler parameters of diastolic dysfunction, including e' (r = -0.338, P =.005), a' (r = -0.350, P =.005), and E/e' (r = 0.334, P =.005).

Conclusions: TIMP-1 is thought to increase tissue concentrations of collagen type I by preventing its breakdown by MMPs. Our findings therefore add weight to a hypothesis suggesting that TIMP-1 may be a key mediator of LV diastolic dysfunction through definition of ventricular matrix composition.

Citing Articles

Involvement of Matrix Metalloproteinases in COVID-19: Molecular Targets, Mechanisms, and Insights for Therapeutic Interventions.

Salomao R, Assis V, de Sousa Neto I, Petriz B, Babault N, Durigan J Biology (Basel). 2023; 12(6).

PMID: 37372128 PMC: 10295079. DOI: 10.3390/biology12060843.


Effect of Growth Hormone Treatment on the Concentration of Selected Metabolic Markers in Girls With Turner Syndrome.

Blaszczyk E, Gawlik J, Gieburowska J, Tokarska A, Kimsa-Furdzik M, Hibner G Front Endocrinol (Lausanne). 2022; 13:818735.

PMID: 35769087 PMC: 9234118. DOI: 10.3389/fendo.2022.818735.


Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension.

Kostov K, Blazhev A Bioengineering (Basel). 2022; 9(3).

PMID: 35324807 PMC: 8945798. DOI: 10.3390/bioengineering9030119.


The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Cabral-Pacheco G, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuna J, Perez-Romero B, Guerrero-Rodriguez J Int J Mol Sci. 2021; 21(24).

PMID: 33419373 PMC: 7767220. DOI: 10.3390/ijms21249739.


Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review.

Mashaqi S, Mansour H, Alameddin H, Combs D, Patel S, Estep L J Clin Sleep Med. 2020; 17(3):567-591.

PMID: 33108267 PMC: 7927322. DOI: 10.5664/jcsm.8928.